Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis.
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001168:Arthritis / Q000150:complications*; D002478:Cells, Cultured; D005260:Female; D005734:Gangrene / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000150:complications*; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000032:analysis; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011711:Pyoderma / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011725:Pyridines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D011725:Pyridines; D013449:Sulfonamides; D013450:Sulfones; D014316:Tritium; D011241:Prednisone; D013936:Thymidine